Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Share News (CCC)

Share Price Information for Computacenter (CCC)

Share Price is delayed by 15 minutes
Get Live Data
4,554.00    100.00 (2.25%)
Bid:
4,586.00
Ask:
4,098.00
Spread: -488.00 (-10.641%)
Market Cap: £4.67b
CCC Live PriceLast checked at - London Stock Exchange

Intraday Computacenter Share Chart

Computacenter's full-year pretax profit rises

Thu, 12th Mar 2015 07:40

March 12(Reuters) - Computacenter Plc, a provider ofIT infrastructure services, reported a 51.3 percent jump infull-year pretax profit, helped by growth in the UK.

The company, which also supplies IT equipment and advisescustomers on IT strategy, said pretax profit rose to 76.4million pounds ($114.4 million) for the year ended Dec. 31, from50.5 million pounds a year earlier.

Revenue rose 1.2 percent to 3.11 billion pounds. Revenuefrom UK jumped 10.2 percent to 1.42 billion pounds. ($1 = 0.6677 pounds) (Reporting by Noor Zainab Hussain in Bengaluru; Editing byAnupama Dwivedi)

Related News

LONDON BRIEFING: GSK hails cancer trial success; Plus500 backs outlook
14 mins ago

LONDON BRIEFING: GSK hails cancer trial success; Plus500 backs outlook

(Alliance News) - GSK reports positive Jemperli trial data, while Plus500 posts record first-half revenue. Elsewhere, Heathrow's first-half passenger ...

Tech rebound lifts European shares after three-day slide
3 days ago

Tech rebound lifts European shares after three-day slide

* Tech stocks gain, healthcare lags

LONDON MARKET CLOSE: FTSE 100 held back by AstraZeneca trial setback
3 days ago

LONDON MARKET CLOSE: FTSE 100 held back by AstraZeneca trial setback

(Alliance News) - Heavy falls in AstraZeneca saw London's FTSE 100 underperform European peers, while investors continue to weigh developments in the ...

Computacenter News

LONDON BRIEFING: GSK hails cancer trial success; Plus500 backs outlook
14 mins ago

LONDON BRIEFING: GSK hails cancer trial success; Plus500 backs outlook

(Alliance News) - GSK reports positive Jemperli trial data, while Plus500 posts record first-half revenue. Elsewhere, Heathrow's first-half passenger ...

Tech rebound lifts European shares after three-day slide
3 days ago

Tech rebound lifts European shares after three-day slide

* Tech stocks gain, healthcare lags

LONDON MARKET CLOSE: FTSE 100 held back by AstraZeneca trial setback
3 days ago

LONDON MARKET CLOSE: FTSE 100 held back by AstraZeneca trial setback

(Alliance News) - Heavy falls in AstraZeneca saw London's FTSE 100 underperform European peers, while investors continue to weigh developments in the ...

LONDON MARKET MIDDAY: FTSE 100 misses out on rebound as Astra drops
3 days ago

LONDON MARKET MIDDAY: FTSE 100 misses out on rebound as Astra drops

(Alliance News) - Stock prices in London were mixed at midday on Thursday, with the FTSE 100 underperforming its European peers as a sharp fall in Ast...

WINNERS & LOSERS: Astra down on failed test; Computacenter ups outlook
3 days ago

WINNERS & LOSERS: Astra down on failed test; Computacenter ups outlook

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Thursday.

LONDON BROKER RATINGS: Computacenter gets two price target hikes
3 days ago

LONDON BROKER RATINGS: Computacenter gets two price target hikes

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

LONDON MARKET OPEN: FTSE 100 lags Europe as AstraZeneca sinks
3 days ago

LONDON MARKET OPEN: FTSE 100 lags Europe as AstraZeneca sinks

(Alliance News) - Stock prices in London opened lower on Thursday, with the FTSE 100 lagging behind its European peers as a sharp fall in AstraZeneca ...